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Abstract
Background: Supervised injection sites (SISs) have been effective in reducing health risks among people who
inject drugs (PWID), including those who face issues of homelessness, mental health illness, interactions with local
policing practices, and HIV infection. We investigate the risk behaviours and risk environments currently faced by
potential users of an SIS in Ottawa to establish the need for such a service and to contribute to the design of an
SIS that can address current health risks and reduce harm.
Methods: The PROUD cohort is a community-based participatory research (CBPR) project that examines the HIV risk
environment among people who use drugs in Ottawa. From March to October 2013, 593 people who reported
using injection drugs or smoking crack cocaine were enrolled through street-based recruitment in the ByWard
Market neighbourhood, an area of the city with a high concentration of public drug use and homelessness.
Participants completed a demographic, behavioural, and risk environment questionnaire and were offered HIV
point-of-care testing. We undertook descriptive and univariate analyses to estimate potential use of an SIS by
PWID in Ottawa and to explore risk behaviours and features of the risk environment faced by potential users
of the service.
Results: Of those participants who reported injecting drugs in the previous 12 months (n = 270), 75.2 % (203)
reported a willingness to use an SIS in Ottawa. Among potential SIS users, 24.6 % had recently injected with a
used needle, 19.0 % had trouble accessing new needles, 60.6 % were unstably housed, 49.8 % had been redzoned
by the police, and 12.8 % were HIV positive. Participants willing to use an SIS more frequently injected in public
(OR = 1.98, 95 % CI = 1.06–3.70), required assistance to inject (OR = 1.84, 95 % CI = 1.00–3.38), were hepatitis C
positive (OR = 2.13, 95 % CI = 1.16–3.91), had overdosed in the previous year (OR = 2.00, 95 % CI = 1.02–3.92), and
identified as LGBTQ (OR = 5.61, 95 % CI = 1.30–24.19).
Conclusion: An SIS in Ottawa would be well-positioned to reach its target group of highly marginalized PWID and
reduce drug-related harms. The application of CBPR methods to a large-scale quantitative survey supported the
mobilization of communities of PWID to identify and advocate for their own service needs, creating an enabling
environment for harm reduction action.
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Background
People who use injection drugs (PWID) in Canada con-
tinue to face barriers to accessing primary healthcare
services [1, 2]. This lack of access is particularly signifi-
cant given the high burden of drug-related harm that is
affecting many PWID communities, including high rates
of fatal overdose, cutaneous abscesses and infections,
and blood-borne infections including HIV and hepatitis
C virus (HCV) [3]. To address these harms, a range of
harm reduction services has been developed and imple-
mented primarily in urban centres across the country,
including needle and syringe programmes, opiate substi-
tution services, and community-based primary care
clinics. These services aim to create low-barrier, non-
judgemental access to evidence-based interventions that
improve the health and safety of PWID without requir-
ing any reduction in drug consumption [4]. Though
many of these services have had success in improving
health outcomes and making frequent contact with
PWID, barriers to long-term engagement in care remain
[5]. One approach that has successfully improved en-
gagement in care is the integration of supervised injec-
tion sites (SISs) into the range of health services
available to PWID. SISs can serve as a first, low-barrier
point of access to the wider range of health and harm
reduction services for highly marginalized PWID [6, 7].
SISs are highly targeted harm reduction services that
are effective in reaching the most marginalized commu-
nities of people who use drugs, including high-intensity
injection drug users and those who face issues of
homelessness, mental health illness, involvement with
sex work, interactions with local policing practices, and
concomitant health conditions including HIV and HCV
infection [8]. An SIS is a controlled healthcare setting
where PWID can access clean injection equipment and
inject pre-obtained drugs under the supervision of a
healthcare professional. SISs are also referred to as su-
pervised injection facilities, safer injection sites, and
medically supervised injecting centres, among other la-
bels depending on the context [8]. The service typically
includes harm reduction education, overdose manage-
ment, and referral to health and social services, includ-
ing drug and addiction counselling and treatment [9].
Currently, there are over 90 SISs in operation around
the world, with the majority located in Europe [10].
Most of the research evidence on the impacts of SISs
available in the literature comes from just two facilities:
Insite in Vancouver and the Medically supervised Inject-
ing Centre (MSIC) in Sydney, Australia [8]. The available
research demonstrates that SIS use can lead to decreases
in high-risk injection practices, such as sharing injection
equipment, rushed injecting, injecting in public, unsafe
syringe disposal, and lack of alcohol swabbing of injec-
tion sites [8]. Other reported outcomes include low rates
of overdose within SIS facilities and falling overdose
rates in surrounding neighbourhoods [11–13], increased
timely access to care for injection-related injuries and
addiction treatment services [6, 7], and a lack of negative
impacts on public order and drug-related crime [14, 15].
Despite the evidence that SISs can contribute to the
health, safety, and engagement in care of PWID, there
have been no new government-sanctioned sites estab-
lished in Canada since Insite opened its doors in
Vancouver in 2003. This lack of progress in establishing
new sites does not reflect a lack of need, as drug-related
harms remain prevalent in many urban centres across
the country. HIV prevalence among Ottawa’s 3500 to
6000 PWID is estimated to be among the highest of any
major Canadian city, at between 11 and 20 % [16]. HCV
prevalence is estimated at 60 %, and as many as 98 % of
PWID infected with HIV in Ottawa are co-infected with
HCV [17]. The 2012 Toronto and Ottawa Supervised
Consumption Assessment (TOSCA) study reported that
20 % of people who use drugs in Ottawa had experienced
a non-fatal overdose in the previous 6 months and 14 %
had injected with used needles [18]. In reviewing the evi-
dence of local need, the TOSCA study recommended that
Ottawa would benefit from the establishment of two SISs.
As the potential benefits of establishing an SIS in
Ottawa are being increasingly recognized, issues of ser-
vice access by PWID and context-sensitive service design
must be explored. Previous Ottawa-based SIS feasibility
studies indicated that 75–78 % of PWID in the city
would be willing to use an SIS [1, 18, 19]. The most re-
cent data on willingness to use an SIS in Ottawa was
collected in 2005 highlighting the need for an up-to-date
consultation with the communities of people who use
drugs to inform new service development. There is also
a need to describe the health risks currently faced by po-
tential SIS users to inform the development of health
and harm reduction services that meet current commu-
nity needs.
We apply Rhodes’ ‘risk environment framework’ to in-
form an investigation of the risks for drug-related harms
currently faced by potential users of an SIS in Ottawa
[20]. In the Rhodes model, harm is produced through
the interactions between individuals and the physical, so-
cial, economic, and policy environments in which they
live. Both harm and harm reduction are considered to
be contingent on these environmental contexts. This
framework does not seek to guide a comprehensive in-
vestigation into all of the complex, dynamic, and multi-
level aspects of the risk environment but rather to
highlight the importance of environmental characteris-
tics in shaping risks for drug-related harm [21, 22]. We
undertook a survey to assess the risk behaviours and
specific features of the risk environments currently faced
by potential SIS users that are relevant to the need for
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an SIS in Ottawa and to service design. A deeper under-
standing of the current risk environments faced by
PWID can also inform service development across the
spectrum of harm reduction and healthcare provision.
By developing a research cohort of PWID in the city, we
seek to establish an evaluative baseline from which to
monitor the impact of new health and harm reduction
services in Ottawa, including SISs.
Urban communities that face issues of health inequity
often develop an expert understanding of the complex
risk environments that shape and interact with their
daily lived experience to produce or minimize harm [23,
24]. Community-based participatory research (CBPR)
combines the strengths of academic systems of inquiry
with novel mechanisms of meaningful community par-
ticipation and control at every stage of the research
process to capitalize on this expert knowledge. CBPR
also engages in an iterative cycle of research and action
for social change [25]. This approach benefits research
in a number of ways, including enhanced cultural sensitiv-
ity and validity of data collection and analysis, improved
community trust and engagement, and contextually rele-
vant health interventions [26]. Community engagement
around risk environment knowledge generation has an
additional benefit of effecting change within the social en-
vironment through community mobilization, relationship
building, capacity building, and harm reduction advocacy.
An enabling social environment can influence the success
of new harm reduction services. We merge CBPR princi-
ples with quantitative cohort methods to describe the risk
environments faced by PWID in Ottawa with the aim
of informing new health and harm reduction service
development, including SISs. This novel approach to
community-based quantitative research can serve as a
model for future harm reduction research that seeks
to understand and simultaneously influence the risk
environments faced by PWID.
Methods
Study design
The Participatory Research in Ottawa: Understanding
Drugs (PROUD) study is a prospective cohort study that
seeks to better understand the HIV risk environment
among people who use drugs in Ottawa, Ontario.
PROUD incorporates CBPR principles to actively engage
a community advisory committee (CAC) consisting of
people with drug use experience and their allies. Follow-
ing a community information session hosted in collabor-
ation with the Drug Users Advocacy League in May
2012, eight people with lived experience with drug use,
three allied frontline support workers, and three ex
officio representatives from organizations working to
improve the health and rights of Ottawa’s drug-using
communities were recruited into the CAC and began
meeting monthly to develop and implement the study.
CAC members receive an honorarium of $25 per meet-
ing to support their contribution to all phases of the
research process, including the research design, data col-
lection, analysis, and knowledge translation stages.
Medical student volunteers were also engaged to assist
with the recruitment phase of the study and to provide
participants with a choice of interviewer. In total, 11
peers and 15 medical student volunteers received train-
ing in CBPR methods, HIV and harm reduction, inter-
viewing skills, research ethics, and HIV point-of-care
(POC) testing to prepare for active roles in the partici-
pant recruitment and data collection phases. The POC
HIV test (bioLytical INSTI test) is a rapid test for the de-
tection of HIV antibodies in fingerstick blood. Details of
the training, survey development, and overall CBPR
process in the PROUD study have been described previ-
ously [27].
Participants
From March to December 2013, 858 people were en-
rolled into the PROUD study. Participants were eligible
if they were aged 16 years or older, reported using injec-
tion drugs or smoking crack cocaine in the previous
12 months, and had been living in Ottawa for at least
3 months at the time of their interview. Of these partici-
pants, 593 were recruited in the ByWard Market area of
Ottawa, which has the highest concentration of public
syringe discards in the city [28] and is a likely site of a
future SIS. The current analysis focuses on the 270 par-
ticipants recruited in the ByWard Market who reported
injecting drugs in the 12 months previous to their inter-
view. A targeted, street-based recruitment strategy was
developed by the CAC to capitalize on its expert knowledge
of the often-hidden social networks of PWID in Ottawa.
Recruiters wearing identifying lanyards approached poten-
tial participants in a variety of street-based and public loca-
tions, presented study information cards, followed a verbal
recruitment script to determine interest and eligibility, and
scheduled interview times.
Data collection
At the research site located in the downtown core,
trained peer or medical student researchers administered
a one-time, tablet-based quantitative survey and a volun-
tary POC HIV test for those participants who did not
self-report as HIV positive. English and French-speaking
peer and medical student interviewers were available to
provide participants with the choice of conducting inter-
views in either official language. Consent was obtained
separately for participation in the survey, the POC HIV
test, and for prospective follow-up through data linkages
to provincial health service records available through
the Institute for Clinical Evaluative Sciences (ICES). A
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voluntary opt-in approach was used to solicit partici-
pation in the POC HIV test and the data linkages.
Participants received a cash honorarium of CAN$20.00
after completing the survey portion of the study. Ethical
approval for this study was obtained from the Ottawa
Hospital and the Ottawa Public Health Research Ethics
Boards.
In the study development phase, the CAC developed
survey themes and questions that reflected the experi-
ences and priorities of their communities. These were
then adapted to a survey format by the research coordi-
nators and integrated into a risk environment frame-
work. The survey questionnaire includes individual
health, sociodemographic, and behavioural variables;
aspects of the physical environment, including the loca-
tions of drug use; aspects of the social environment,
including access to social services and peer groups and
local policing practices such as redzoning and stop-
and-search; aspects of the economic environment,
including income, employment, and housing and home-
lessness; and aspects of the policy environment, includ-
ing access to specific health, harm reduction, and social
services [24]. The current descriptive analysis focuses
on items in the questionnaire that characterize the risk
environment of PWID and illustrate the need for an
SIS in Ottawa including the following: types and fre-
quencies of drugs injected, syringe-sharing practices,
public injecting, requiring assistance to inject, lack of
access to services, experience with overdose, and HIV
and HCV infection status. The main outcome variable,
willingness to use an SIS in Ottawa, is based on the
question ‘Would you likely use a supervised injection
site if one was opened in Ottawa?’. All participants
were provided with a brief definition of an SIS before
being asked about their willingness to use one.
Statistical analysis
All analyses were conducted using SPSS Version 22.0.
We undertook descriptive and univariate analysis to esti-
mate the potential use of an SIS by PWID in Ottawa
and to explore characteristics of the risk environments
faced by those who are willing and not willing to use the
service. To explore whether there is a statistical differ-
ence between the risk environments faced by those who
are and those who are not willing to use an SIS, categor-
ical and explanatory variables were analysed using the
Pearson χ2 test, and continuous variables were analysed
using the Wilcoxon rank sum test. Unadjusted odds ra-
tios (ORs) with corresponding 95 % confidence intervals
(CIs) were calculated and all reported p values are two-
sided. Several variables included in the analysis have
missing data due to participants refusing to respond.
This is not surprising given the highly sensitive nature of
the questionnaire. All refuse-to-answer responses were
treated as missing data, rather than re-categorizing miss-
ing responses for analysis.
Results
Demographics, drug use, and health
Of the 593 participants recruited in the ByWard Market,
45.5 % (270) reported injecting drugs in the previous
12 months. Table 1 shows the demographic, drug use,
health, and risk environment characteristics of these 270
participants. The median age was 42 years. Among these
PWID, 15.2 % (41) spoke French as their first language
and 49.3 % (133) lived in the ByWard Market or the lar-
ger Lowertown area of Ottawa. Almost one quarter of
PWID participants were female (62 or 23.0 %), and
nearly one fifth identified as Aboriginal (47 or 17.4 %).
When asked their opinion on SISs, 84.8 % (229) thought
there should be an SIS in Ottawa, and 75.2 % (203) re-
ported that they would use an SIS if one were to open in
the city. More than half of the 203 potential SIS users
reported that they would use the service daily if it
opened right away (103 or 50.7 %). Among those partici-
pants who expressed willingness to use an SIS (n = 203),
72.9 % (148) injected morphine, 70.4 % (143) injected
cocaine, 56.2 % (114) injected crack-cocaine, and 45.8 %
(93) injected heroin within the previous year. Almost
half (46.3 %) reported injecting opiates a few times a
week or more. When questioned about health outcomes,
74.9 % (152) of potential SIS users reported ever having
been diagnosed with a mental health illness, 63.5 %
(129) tested positive for HCV at their last test, and
12.8 % (26) self-reported that they were HIV positive.
Risk environment characteristics
Public injecting is a key marker of the physical risk en-
vironment and was common among potential SIS users
at 39.5 % (81) [24]. Interactions with local policing prac-
tices, a characteristic of the social risk environment,
were also common with 74.4 % (151) having been
stopped and searched by the police without arrest and
47.8 % (97) having been kept overnight or longer in
prison, jail, or a detention centre in the previous
12 months. Aspects of the policy risk environment in-
clude availability and access to health and harm reduc-
tion services. Among potential SIS users, 19.2 % (39)
had trouble accessing new needles, 39.4 % (80) had
accessed addictions treatment in the past 12 months,
and 43.8 % (89) had sought care in a hospital/ER in the
previous year. Characteristics of the economic risk envir-
onment include housing, employment, and income. As
many as 94.1 % (191) of potential SIS users had ever
been homeless, and 60.6 % (123) were unstably housed
at the time of their interview (defined as living in a
rooming house, shelter, or on the street/homeless).
Almost half had a monthly income of $999 or less
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(48.8 %), 49.7 % (101) relied on a food bank or shelter
for 75 % or more of their meals, and 57.1 % (116) had
not completed high school.
Univariate analysis
In univariate analysis, those willing to use an SIS were
more often younger (42 vs. 44 years, p = 0.04), identified
as LGBTQ (OR = 5.61, 95 % CI = 1.30–24.19), injected in
public (OR = 1.98, 95 % CI = 1.06–3.70), injected with
other people (OR = 3.23, 95 % CI = 1.66–6.27), required
assistance to inject (OR = 1.84, 95 % CI = 1.00–3.38), had
overdosed in the past 12 months (OR = 2.00, 95 % CI =
1.02–3.92), and had tested positive for HCV at their last
test (OR = 2.13, 95 % CI = 1.16–3.91) (Table 2).
Discussion
Potential uptake of an SIS in Ottawa is high with more
than three quarters of PWID PROUD study participants
reporting a willingness to use the service. This is consist-
ent with previous feasibility studies which indicate a
relatively stable demand for the service over time [1, 18,
19]. A study on the validity of such feasibility assess-
ments in Vancouver found that reporting an initial will-
ingness to use an SIS was a significant predictor of later
use of the service, with 72 % of those who reported an
initial willingness later attending the programme [29].
The sub-population of PWID who are likely to use an
SIS currently faces complex risk environments for drug-
related harm. Many of these harms and several aspects
of the risk environment could potentially be addressed
through the development of supervised injection services
that are responsive to the local context.
The demographic, health, and drug use variables de-
scribed here have implications for supervised injection
service development. Those PWID who were younger or
identified as LGBTQ expressed willingness to use an SIS
more frequently than older individuals and those who
did not identify as LGBTQ. This illustrates the potential
of an Ottawa-based SIS to reach and engage communi-
ties who face multiple and intersecting oppressions sim-
ultaneously. These findings may indicate an increased
Table 1 Demographic, behavioural, and risk environment
characteristics disaggregated by willingness to use an SIS in
Ottawaa
Intention to use an SIS
in Ottawa; no. (and %)
of participantsb
Characteristicc Yes No
n = 205 n = 67
Demographics, drug use, health
Age (median) 42.0 44.0
Female 52 (25.4) 10 (14.9)
French-speaking 30 (14.6) 11 (16.4)
Aboriginal identity 39 (19.0) 8 (11.9)
Market/Lowertown residence 99 (48.3) 35 (52.2)
LGBTQ identity 29 (14.1) 2 (3.0)
Injected crack cocaine 114 (55.6) 17 (25.4)
Injected speedball 63 (30.7) 8 (11.9)
Injected fentanyl 79 (38.5) 11 (16.4)
Injected heroin 93 (45.4) 15 (22.4)
Injected dilaudid 133 (64.9) 29 (43.3)
Injected morphine 148 (72.2) 36 (53.7)
Injected cocaine 143 (69.8) 35 (52.2)
Injected opiates a few times a week or more 94 (45.9) 20 (29.9)
Overdosed 66 (32.2) 13 (19.4)
Ever tested HIV positive 26 (12.7) 6 (9.0)
Last hep C test positive 129 (62.9) 32 (47.8)
Mental health diagnosis (ever) 152 (74.1) 52 (77.6)
Attempted suicide 17 (8.3) 4 (6.0)
Would use SIS daily 103 (50.2) NA
Physical risk environment
Injects in public 81 (39.5) 17 (25.4)
Used unknown needle 34 (16.6) 7 (10.4)
Injected with used needle 50 (24.4) 10 (14.9)
Injects with other people 176 (85.9) 44 (65.7)
Assistance to inject 81 (39.5) 18 (26.9)
Social risk environment
Ever redzonedd 102 (49.8) 20 (29.9)
Stopped/searched by police 151 (73.7) 45 (67.2)
Kept overnight or longer in jail 97 (47.3) 32 (47.8)
Policy risk environment
Trouble accessing new needles 39 (19.0) 6 (9.0)
Access addiction treatment 80 (39.0) 26 (38.8)
Have regular doctor 113 (55.1) 33 (49.3)
Sought care in hospital/ER 89 (43.4) 27 (40.3)
Tested for HIV (ever) 188 (91.7) 57 (85.1)
Economic risk environment
Received drugs, $, gifts for sex 38 (18.5) 6 (9.0)
Table 1 Demographic, behavioural, and risk environment
characteristics disaggregated by willingness to use an SIS in
Ottawaa (Continued)
Sex work primary source of income 13 (6.3) 4 (6.0)
Unstably housed 123 (60.0) 32 (15.6)
Homeless past 12 months 164 (80.0) 47 (22.9)
aPercentages are calculated within the subgroups of participants willing or not
willing to use an SIS
bBecause of missing responses, the data for some characteristics do not sum
to 272
cAll variables are reported for the previous 12 months unless otherwise specified
dRedzones are defined as any geographical area or neighborhood where law
enforcement had restricted the participant’s movement
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awareness and support for particular harm reduction
services among these groups, though the reasons for
such high interest in using an SIS remain to be explored.
In the year preceding their interview, nearly a quarter
of potential SIS users in Ottawa had used a syringe that
they knew had been used by someone else and nearly
half injected opiates several times a week or more. Fre-
quent injecting and syringe sharing are associated with
increased risk of transmission of blood-borne infections
[30]. SIS use in other contexts has been associated with
a decrease in syringe sharing [31]. There is also evidence
of significant polysubstance use in the cohort. Polysub-
stance use has been associated with negative health out-
comes including HCV infection and overdose [32–34].
Efforts to engage and accommodate frequent injectors
and polysubstance users in future SIS and other harm
reduction services in Ottawa should be prioritized.
Potential SIS users also experienced a high burden of
negative health outcomes, with high rates of mental
health diagnoses (74.9 %) and HIV infection (12.8 %)
and a higher burden of overdoses and HCV infection
than those unwilling to use the service. Insite has had a
measurable impact on the burden of overdoses in
Vancouver, demonstrating a 35 % reduction in the fatal
overdose rate surrounding the site just 2 years after
opening [11]. The TOSCA study estimates that 6–10
new HIV infections and 20–35 new hepatitis C infec-
tions could be averted per facility per year by the first
two SIS facilities in Ottawa, although the prevention po-
tential of additional facilities is considerably lower [18].
A recent analysis of the costs and benefits that could be
expected if Ottawa were to open an SIS found that the
service appears to be an efficient and effective use of fi-
nancial resources based on savings from the prevention
of HIV and HCV cases alone [35]. However, the poten-
tial of an SIS to improve health outcomes is limited by
the suitability of the service model to the needs of po-
tential users. In Vancouver’s SIS, nurses and other cli-
ents are not permitted to physically assist a client with
an injection. This regulation has been associated with re-
duced access to the site among some high-risk groups
[36]. In the current study, potential SIS users reported
requiring assistance to inject more frequently than
PWID who did not report a willingness to use the site.
An SIS in Ottawa should consider developing ap-
proaches and regulations for engaging and supporting
PWID who require assistance to inject.
When compared to participants who did not report
willingness to use an SIS, potential SIS users injected in
public more frequently. Public injection locations are
often characterized by unhygienic conditions and expos-
ure to street violence and the police, which can lead to
rushed injecting [37]. Because of these characteristics of
the physical environment, public injecting has been as-
sociated with negative health outcomes including over-
dose and HIV and HCV infection [38]. In the 12 weeks
following the opening of Vancouver’s SIS, there was a
significant reduction in the number of drug users inject-
ing in public, publicly discarded syringes, and injection-
related litter [39]. An SIS in Ottawa could provide a
safer physical environment for many PWID currently
exposed to public-injection-related risks and improve
public order in the surrounding neighbourhood [39].
Limitations to accessing the service, such as long wait
times, were independently associated with persistent
public injection in a cohort of IDU recruited from the
SIS in Vancouver, demonstrating the importance of ac-
cessibility in harnessing the potential of SISs to alter the
physical environments of risk for PWID [40].
Aspects of the social environment examined in this
study include experiences of policing practices. Three
quarters of potential SIS users had been stopped and
searched by the police in the previous 12 months, and
half had been redzoned, meaning their movement in a
Table 2 Risk environment comparison by willingness to use a
supervised injection service in Ottawaa
Intention to use an SIS
in Ottawa; no. (and %)
of participantb
Characteristicc Yes No OR (and
95 %CI)dn = 205 n = 67
Age 42.0 44.0 p value = 0.04
Sexual identity
LGBTQ 29 (93.5) 2 (6.5) 5.61 (1.30–24.19)
Straight 168 (72.1) 65 (27.9)
Injects with other people
Yes 176 (80.0) 44 (20.0) 3.23 (1.66–6.27)
No 26 (55.3) 21 (44.7)
Injects in public
Yes 81 (82.7) 17 (17.3) 1.98 (1.06–3.70)
No 113 (70.6) 47 (29.4)
Assistance to inject
Yes 81 (81.8) 18 (18.2) 1.84 (1.00–3.38)
No 120 (71.0) 49 (29.0)
Last hep C test
Positive 129 (80.1) 32 (19.9) 2.13 (1.16–3.91)
Negative 51 (65.4) 27 (34.6)
Overdosed
Yes 66 (83.5) 13 (16.5) 2.00 (1.02–3.92)
No 137 (71.7) 54 (28.3)
OR odds ratio, CI confidence interval
aPercentages are calculated on the basis of the sum across each row
bExcept where indicated otherwise. Because of missing responses, the data for
some characteristics do not sum to 272
cVariables are reported for the previous 12 months unless otherwise specified
dFor each categorical variable, the reference category is the second category
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particular geographical area or neighbourhood had been
restricted by law enforcement. If these policing practices
continue in the area where a new SIS is opened, they
could have important negative implications for service
access [20]. The police are therefore key stakeholders
that should be engaged in developing an enabling social
environment for harm reduction.
Other important aspects of the social environment are
the knowledge and relationships within the communities
of PWID which shape community norms and support
effective mobilization for harm reduction advocacy [24].
The application of CBPR principles to the PROUD re-
search process helped to support the development of
new community leadership and increased mobilization
on harm reduction issues, expanding the reach of exist-
ing peer advocacy efforts and supporting the develop-
ment of new relationships of solidarity. These are
described by Duff as key elements of an ‘enabling’ social
environment for harm reduction [41]. CAC members
participated in significant community outreach and edu-
cation throughout the study recruitment and knowledge
translation. Study participants responded positively to
seeing community members in leadership and research
roles and generally did not state a preference for medical
student or community member interviewers or HIV tes-
ters. The broader community impacts of this model have
been visible in the high levels of PWID attendance at
thematic community forums and advocacy events where
ten plain-language PROUD newsletters have been re-
leased since October 2012. At these forums and advo-
cacy events, PROUD study results have been presented
by the CAC to community members and service pro-
viders for feedback and discussion. The link between re-
search and social action that is forged through CBPR
methods can reduce harm in its own right and help fos-
ter a social environment conducive to effective harm re-
duction [41].
Aspects of the economic risk environment, including
homelessness, food insecurity, and lack of access to edu-
cation, were also highly prevalent among potential SIS
users. SISs in other contexts have had success in en-
gaging PWID who face these complex social determi-
nants of health [8]. In a review of 14 studies from
Vancouver, Sydney, Geneva, Madrid, and Barcelona, the
majority of the most frequent SIS users had a previous
history of incarceration and faced issues of housing inse-
curity and unemployment [8]. In terms of the policy en-
vironment, access to healthcare was not found to be
significantly different between those who would and
those who would not use an SIS, though both groups re-
ported barriers to care. Nearly one fifth of potential SIS
users had trouble accessing new needles, and more than
60 % had not accessed any addiction treatment in the
past year. The high rate of hospital emergency room use
(43.9 %) has been observed among other PWID popula-
tions and is linked to barriers to accessing primary care
services [2, 42]. Use of an SIS has been shown to in-
crease timely access to care for injection-related injuries
and infections [6] and increase uptake of addiction treat-
ment services [7]. Economic risks and other barriers to
accessing care can interfere with access to harm reduc-
tion services, including SISs. Ongoing engagement of
PWID in harm reduction research and service design
can help to identify and address context-specific access
barriers as they arise.
Although an SIS can improve engagement across the
spectrum of health and harm reduction services through
service referrals and integration, it is clear that not all
PWID would be willing to use an SIS and not all who
are willing would have access. Though the focus of this
paper is on the risk environments faced by potential
users of SIS services, it is important to consider the po-
tential unmet needs of those who report a lack of will-
ingness to use the service. In the current study, those
not willing to use an SIS if one were available more fre-
quently reported not injecting in public and not inject-
ing with other people. A previous study of willingness to
use SIS services in Vancouver identified injection at
home, already having a safe place, and willingness to in-
ject in private as the major reasons not to use the SIS
[43]. The harm reduction needs of those who inject
alone in private residences are important to explore in
future research. Other context-specific barriers and
reasons for not accessing SIS services should also be
investigated.
There are several limitations to the current study.
Though probability sampling is not feasible in this hard-
to-reach population, our street-based and peer-driven
recruitment approach has the potential to identify popu-
lations with the highest health risk behaviours [44]. The
CAC elected to recruit during daylight hours due to
group safety concerns, which could reduce the represen-
tation of sex workers and other community members
who are primarily available at night. Recruiters targeted
street-involved PWID, which mirrors the target popula-
tion of an SIS. However, this targeting leads to an over-
representation of homeless and socially marginalized
PWID, which may not be representative of all PWID in
Ottawa or in other settings. An additional limitation is
our outcome measure, which assesses hypothetical use
of a future site. To further explore the uptake and im-
pact of an SIS on drug-related harm in Ottawa, service
providers should develop and implement a rigorous
monitoring and evaluation programme to assess the real
benefit of a site once opened.
As the survey relies on self-reported data, study results
may be influenced by social desirability bias. Since re-
spondents were asked about practices that are highly
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stigmatized or illegal, this bias would likely result in an
underestimation of high-risk practices. Missing data is
generally the result of participant non-response to ques-
tions they would prefer not to answer and would also
likely result in an underestimation of high-risk practices.
The current study reports descriptive and univariate
statistics to give a preliminary overview of some features
of the risk environments faced by PWID in Ottawa to
inform new health and harm reduction service develop-
ment. However, this descriptive approach precludes the
identification of independent associations between vari-
ous risk factors and their influence on drug-related
harms and harm reduction service access. The use of
cross-sectional data limits our ability to predict willing-
ness to use an SIS based on specific health risks or
service user characteristics. Rhodes [24] highlights the
difficulty of isolating the individual effects of risk envir-
onment characteristics on harm and access to harm re-
duction services given the non-linear relationships that
exist between multilevel characteristics of these environ-
ments, which interact with each other and with individ-
ual agency to cause dynamic changes over time and
place. Future research should seek to characterize these
dynamic associations between different aspects of the
risk environment and the use and effects of harm reduc-
tion services.
Since this study captures self-report of different as-
pects of the risk environment as experienced by individ-
uals, it examines the ‘micro’-level of Rhodes’ [20]
environmental influence categorization, omitting macro-
level elements of the risk environment such as national
and regional policies, laws, and economic resources. As
a result, this study captures only a fraction of the com-
plex contextual elements that shape or interact with risk
for harm and access to harm reduction among PWID.
The CBPR methods used in this study ensure that the
aspects of the risk environment examined reflect the pri-
orities of the communities of PWID who would be af-
fected by a future SIS.
Conclusion
Like many cities across Canada, PWID in Ottawa con-
tinue to face significant risks of drug-related harm and
barriers to accessing appropriate care. This study dem-
onstrates that there would be high uptake of an SIS if
established in Ottawa, that the service has the potential
to reach its target population of marginalized PWID,
and that an SIS tailored to the context-specific needs of
the local population could potentially address important
aspects of the risk environments faced by PWID. This
study has implications for harm reduction beyond the
Ottawa context in two respects. First, it highlights the
utility of the risk environment framework for informing
quantitative cohort study research investigating the
context-specific harm reduction needs of PWID. Second,
it demonstrates the potential to merge quantitative sur-
vey methods with CBPR principles to foster meaningful
community ownership and control over the research
process and support communities of PWID in identify-
ing and advocating for their own service needs.
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